Versant Venture Capital VI, L.P.
CIK 0001687880 Name as filed on the most recent filing
Filed as Versant Venture Capital VI, L.P. (51)
186 transaction lines · from 51 filings · filed 2019-06-25 to 2025-10-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Lenz Therapeutics, Inc. 9 filings
- ISSUER Lava Therapeutics NV 2 filings
- ISSUER Monte Rosa Therapeutics, Inc. 4 filings
- ISSUER Black Diamond Therapeutics, Inc. 16 filings
- ISSUER Tempest Therapeutics, Inc. 1 filings
- ISSUER Century Therapeutics, Inc. 2 filings
- ISSUER Repare Therapeutics Inc. 2 filings
- ISSUER Oyster Point Pharma, Inc. 2 filings
- ISSUER Aligos Therapeutics, Inc. 1 filings
- ISSUER Akero Therapeutics, Inc. 11 filings
- ISSUER Passage BIO, Inc. 1 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
13 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2025-09-30 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 83,066 disposed | 46.41 | 3,854,827.25 | Form 4, filing 0001193125-25-228493 | |
| 2025-09-30 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 57,502 disposed | 46.41 | 2,668,483.81 | Form 4, filing 0001193125-25-228493 | |
| 2025-09-30 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 49,701 disposed | 45.35 | 2,254,173.94 | Form 4, filing 0001193125-25-228493 | |
| 2025-09-30 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 34,405 disposed | 45.35 | 1,560,428.45 | Form 4, filing 0001193125-25-228493 | |
| 2025-09-30 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 177 disposed | 47.01 | 8,321.35 | Form 4, filing 0001193125-25-228493 | |
| 2025-09-30 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 123 disposed | 47.01 | 5,782.64 | Form 4, filing 0001193125-25-228493 | |
| 2025-09-19 |
Lava Therapeutics NV LVTX |
S, Open-market sale | 2,370,533 disposed | 1.40 | 3,322,064.95 | Form 4, filing 0001193125-25-213445 | |
| 2025-09-19 |
Lava Therapeutics NV LVTX |
S, Open-market sale | 532,870 disposed | 1.40 | 746,764.02 | Form 4, filing 0001193125-25-213445 | |
| 2025-09-18 |
Lava Therapeutics NV LVTX |
S, Open-market sale | 366,111 disposed | 1.44 | 527,858.84 | Form 4, filing 0001193125-25-207677 | |
| 2025-09-18 |
Lava Therapeutics NV LVTX |
S, Open-market sale | 228,791 disposed | 1.44 | 329,870.86 | Form 4, filing 0001193125-25-207677 | |
| 2025-09-18 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 49,479 disposed | 41.59 | 2,057,871.19 | Form 4, filing 0001193125-25-211363 | |
| 2025-09-18 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 40,907 disposed | 43.00 | 1,759,156.45 | Form 4, filing 0001193125-25-211363 | |
| 2025-09-18 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 24,370 disposed | 41.59 | 1,013,567.80 | Form 4, filing 0001193125-25-211363 | |
| 2025-09-18 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 20,148 disposed | 43.00 | 866,440.56 | Form 4, filing 0001193125-25-211363 | |
| 2025-09-18 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 268 disposed | 43.30 | 11,604.40 | Form 4, filing 0001193125-25-211363 | |
| 2025-09-18 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 132 disposed | 43.30 | 5,715.60 | Form 4, filing 0001193125-25-211363 | |
| 2025-09-17 |
Lava Therapeutics NV LVTX |
S, Open-market sale | 362,806 disposed | 1.49 | 540,290.70 | Form 4, filing 0001193125-25-207677 | |
| 2025-09-17 |
Lava Therapeutics NV LVTX |
S, Open-market sale | 226,726 disposed | 1.49 | 337,640.36 | Form 4, filing 0001193125-25-207677 | |
| 2025-09-16 |
Lava Therapeutics NV LVTX |
S, Open-market sale | 307,707 disposed | 1.53 | 471,776.37 | Form 4, filing 0001193125-25-207677 | |
| 2025-09-16 |
Lava Therapeutics NV LVTX |
S, Open-market sale | 192,293 disposed | 1.53 | 294,823.63 | Form 4, filing 0001193125-25-207677 | |
| 2025-08-26 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 43,978 disposed | 38.97 | 1,714,016.16 | Form 4, filing 0000950170-25-111529 | |
| 2025-08-26 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 21,661 disposed | 38.97 | 844,224.48 | Form 4, filing 0000950170-25-111529 | |
| 2025-08-26 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 3,465 disposed | 39.50 | 136,875.12 | Form 4, filing 0000950170-25-111529 | |
| 2025-08-26 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 1,707 disposed | 39.50 | 67,430.26 | Form 4, filing 0000950170-25-111529 | |
| 2025-08-25 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 50,270 disposed | 39.53 | 1,986,946.88 | Form 4, filing 0000950170-25-111529 | |
| 2025-08-25 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 24,760 disposed | 39.53 | 978,651.38 | Form 4, filing 0000950170-25-111529 | |
| 2025-08-25 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 2,149 disposed | 39.92 | 85,790.66 | Form 4, filing 0000950170-25-111529 | |
| 2025-08-25 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 1,058 disposed | 39.92 | 42,236.63 | Form 4, filing 0000950170-25-111529 | |
| 2025-08-22 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 20,493 disposed | 40.03 | 820,328.64 | Form 4, filing 0000950170-25-111529 | |
| 2025-08-22 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 10,076 disposed | 40.03 | 403,339.26 | Form 4, filing 0000950170-25-111529 | |
| 2025-08-22 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 5,668 disposed | 40.59 | 230,063.55 | Form 4, filing 0000950170-25-111529 | |
| 2025-08-22 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 2,809 disposed | 40.59 | 114,017.03 | Form 4, filing 0000950170-25-111529 | |
| 2025-08-18 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 30,628 disposed | 38.56 | 1,181,049.37 | Form 4, filing 0000950170-25-110163 | |
| 2025-08-18 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 15,085 disposed | 38.56 | 581,694.19 | Form 4, filing 0000950170-25-110163 | |
| 2025-08-15 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 145,051 disposed | 39.50 | 5,729,514.50 | Form 4, filing 0000950170-25-110163 | |
| 2025-08-15 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 69,949 disposed | 39.50 | 2,762,985.50 | Form 4, filing 0000950170-25-110163 | |
| 2025-07-10 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 191,376 disposed | 34.00 | 6,506,784.00 | Form 4, filing 0000950170-25-095616 | |
| 2025-06-27 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 200,000 disposed | 30.46 | 6,093,000.00 | Form 4, filing 0000950170-25-092373 | |
| 2025-06-20 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 133,924 disposed | 30.25 | 4,051,201.00 | Form 4, filing 0000950170-25-088604 | |
| 2025-06-20 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 100,877 disposed | 30.35 | 3,061,616.95 | Form 4, filing 0000950170-25-088604 | |
| 2025-06-18 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 100,000 disposed | 29.95 | 2,995,000.00 | Form 4, filing 0000950170-25-088604 | |
| 2025-06-10 |
Lenz Therapeutics, Inc. LENZ |
S, Open-market sale | 350,000 disposed | 29.00 | 10,150,000.00 | Form 4, filing 0000950170-25-085490 | |
| 2024-10-29 |
Monte Rosa Therapeutics, Inc. GLUE |
S, Open-market sale | 52,305 disposed | 9.08 | 475,007.86 | Form 4, filing 0000950170-24-119051 | |
| 2024-10-29 |
Monte Rosa Therapeutics, Inc. GLUE |
S, Open-market sale | 15,600 disposed | 9.41 | 146,792.88 | Form 4, filing 0000950170-24-119051 | |
| 2024-10-28 |
Monte Rosa Therapeutics, Inc. GLUE |
S, Open-market sale | 89,990 disposed | 9.66 | 869,240.41 | Form 4, filing 0000950170-24-119051 | |
| 2024-09-20 |
Monte Rosa Therapeutics, Inc. GLUE |
S, Open-market sale | 1,132,566 disposed | 6.53 | 7,395,202.95 | Form 4, filing 0000950170-24-109112 | |
| 2024-09-13 |
Monte Rosa Therapeutics, Inc. GLUE |
S, Open-market sale | 9,269 disposed | 6.16 | 57,099.82 | Form 4, filing 0000950170-24-106532 | |
| 2024-09-12 |
Monte Rosa Therapeutics, Inc. GLUE |
S, Open-market sale | 16,047 disposed | 6.00 | 96,309.28 | Form 4, filing 0000950170-24-106532 | |
| 2024-09-11 |
Monte Rosa Therapeutics, Inc. GLUE |
S, Open-market sale | 541,897 disposed | 6.00 | 3,251,382.00 | Form 4, filing 0000950170-24-106532 | |
| 2024-08-28 |
Black Diamond Therapeutics, Inc. BDTX |
S, Open-market sale | 221,600 disposed | 6.32 | 1,400,556.32 | Form 4, filing 0000950170-24-102354 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 1
- Open-market sale 12
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Versant Venture Capital VI, L.P., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001687880
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6